For the first time a position statement has been published providing clinicians with guidance on how to help people with Cardiovascular disease (CVD) and diabetes start exercising safely again. ...
The use of sodium-glucose co-transporter-2 (SGLT2) inhibitors in type 2 diabetes if albuminuria is greater than 30mg/mmol is a key change in the newly amended NICE guidance for Chronic Kidney ...
The introduction of a new enhanced service on obesity and weight management with NHS England is set to be discussed by the British Medical Association’s (BMA’s) GP Committee (GPC). The aim ...
Liraglutide has been officially approved as an obesity treatment on the NHS for people with pre-diabetes under the care of specialist weight loss clinics. NICE has now given the thumbs up for the ...
A link between severe COVID-19 infections and new cases of diabetes in some people has been discovered in preliminary research. Doctors have known for a while that people with diabetes are more ...
The NHS Diabetes Programme has commissioned two online programmes for people with type 1 diabetes in response to the COVID-19 pandemic. A resource pack to support localities in promoting the ...